drugset / Trial / NCT01551797

A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations.

NCT01551797

Phase 1 Completed 14 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This proof of principle study will evaluate an experimental formulation of paracetamol that is being developed for eventual long lasting use. This study is also used for drug safety evaluation.

Timeline

Start
2010-05
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 500 mg Oral
Comparator Acetaminophen Small molecule 750 mg Oral
Comparator Acetaminophen Small molecule 1000 mg Oral

Indications

No indication recorded.